
http://www.healasthma.com
- Merck Announces Full-Year Earnings Per Share -EPS- of . , Fourth-Quarter EPS of Cents Merck & Co., Inc. Media Contacts Tony Plohoros, – - Anita Larsen, – - or Investor Contact Graeme Bell, – - Merck & Co., Inc. (NYSE MRK) — Merck Reaffirms Full-Year EPS Range of . to . — Merck Anticipates First-Quarter EPS of to Cents — Merck Reserves an Additional Million in the Fourth Quarter Solely for Future Legal Defense Costs for VIOXX, Bringing Total Reserve to Million … . FD (FAIR DISCLOSURE) WIRE – Q Merck & Co., Inc. Earnings Conference Call – Final OPERATOR Good day, and welcome to the Merck nd quarter earnings conference call. Today’s call is being recorded. At this time I’d like to turn the floor over to Mr. Mark Stejbach, Senior Director of Investor Relations with Merck. Please go ahead, sir. MARK STEJBACH, SENIOR DIRECTOR OF IR, MERCK & CO. INC. Thank you, and good morning everybody. Welcome to our nd quarter call. You should have the press release by now.If you are on our email… ‘Richer than God,’ and playing it too When our -year-old son, newly graduated from a two-year college and not yet working, went to the pharmacy for asthma medication Thursday, he left empty-handed.His pill-a-day prescription for Singulair, an allergy drug, was ready and waiting. But he didn’t have the he needed to pay for a three-month supply and that’s with HMO prescription coverage, which he won’t have much longer. It’s far more costly without.Since he’d… . HEALTH NEWS BRIEFS Renamed health project gears up The th annual Project Healthy Living (formerly known as Project Health-O-Rama) will begin Sunday and run through at more than sites in the city of Detroit and the counties of Lapeer, Livingston, Macomb, Monroe, Oakland, Sanilac, St. Clair, Washtenaw and Wayne.The project, mounted by , volunteers and agencies, offers free or low-cost health screenings. Free tests at all sites include blood pressure, height and weight, vision,… . The Hartford Courant – HOSPITAL TO PARTICIPATE IN ASTHMA DRUG RESEARCH New Britain General Hospital has been chosen as one of the first hospitals in the country to be involved with new research on controlling asthma.The hospital has enrolled patients in a clinical trial being conducted by Merck pharmaceutical company and the U.S. Food and Drug Administration. The study involves the use of the drug montelukast, also called Singulair. The drug is on the market as a treatment for asthma, but the trial is using it in intravenous form to treat people suffering… . Stuart News, The DISCUSS TREATMENT FOR ASTHMA WITH PHYSICIAN Editor On page D of the Feb. News, in the health column, Dr. Peter Gott mentions new medicines for asthma. Although these medications were described as antagonizing the actions of leukotrienes, zafirlukast (Accolate) and montelukast (Singulair) block the leukotriene inflammatory process by a different mechanism from zileuton (Zyflo).In the column, Gott mentions “… my consultants tell me that the medicines are very useful in preventing the wheezing and difficulty… . Asian News International – Girls, kids exposed to tobacco smoke respond well to montelukast Report from Asian News International brought to you by HT Syndication.Washington, — Researchers at National Jewish Medical and Research Center have found that girls and children exposed to tobacco smoke respond particularly well to montelukast (Singulair).Nathan Rabinovitch, MD, Associate Professor of Paediatrics, and his colleagues also identified two biomarkers that might help doctors predict even more precisely which patients will benefit from montelukast…. KTHV (Little Rock-Pine Bluff, AR) – Early cut-in – TIME START ONE PILL, ONCE A DAY SIDE EFFECTS ARE GENERALLY MILD A ND VARY BY AGE AND INCLUDE HEAD ACHE, EAR INFECTION, SORE THROAT AND UPPER RESPIRATORY INFECTION.SINGULAIR.A DIFFERENT WAY TO TREAT ALLERGIES.>IN OUR NEXT HOUR, WE’RE GOING TO TAKE A LOOK AT T HIS STUDY, A LUNG CANCER STUDY FUNDED BY A TOBACCO COMPANY.TALK ABOUT A CONFLICT OF INTEREST.WE’LL TAKE A CLOSER LOOK…. . ABC – WLS (Chicago, IL) – ABC News @ PM – TIME START Woo-Woo The Astelins?It could be Allergies Gettin’ To you But Irritants can cause your Symptoms too TIME START Caused by Irritants.Nasonex, Singulair and Zyrtec aren’t.Astelin is for People and over.TIME START Or Irritants do you in…Ask your Doctor ‘Bout…Astelin TIME START A Fire Truck responding to a call Collides with a School Butts…. Research And Markets The Novel Mechanism Proposed By Rigels R For The Treatment Of Allergic Rhinitis Has A Solid Scientific Rationale, And Is Favored By Opinion Leaders. Research and Markets Laura Wood press@researchandmarkets.com Fax + Research and Markets (http://www.researchandmarkets.com/reports/c ) has announced the addition of Rigels Allergic Rhinitis Candidate – R to their offering In a therapeutic area where mature products dominate, R is a promising treatment with a novel mechanism of action, likely to demonstrate clinical superiority to Mercks Singulair (montelukast) in the treatment of allergic rhinitis. The main… –

http://www.healasthma.com |